Affinity purification of heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia: biological characteristics and effects on platelet activation

被引:51
|
作者
Amiral, J
Pouplard, C
Vissac, AM
Walenga, JM
Jeske, W
Gruel, Y
机构
[1] Hop Trousseau, Lab Hematol Hemostase, F-37044 Tours 1, France
[2] HYPHEN BioMed, F-78570 Andresy, France
[3] Loyola Univ, Med Ctr, Hemostasis Res Labs, Maywood, IL 60153 USA
关键词
heparin-induced thrombocytopenia; antibodies to heparin PF4; platelet activation;
D O I
10.1046/j.1365-2141.2000.02034.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antibodies to heparin platelet factor 4 (H-PF4) complexes were purified from the plasma of three patients with heparin-induced thrombocytopenia (HIT) using affinity chromatography. From each plasma, the largest amount of antibodies was eluted with 2 M NaCl at pH 7.5 (peak 1) and the remainder was obtained using 0.1 M glycine/0.5 M NaCl at pH 2.5 (peak 2). In an enzyme-linked immunosorbent assay (ELISA), we then showed that each patient had developed antibodies to PF4 displaying different characteristics. In patient 1, peak 1 IgG reacted almost exclusively with H-PF4 complexes, whereas peak 2 IgG had similar reactivity with PF4 whether or not heparin was present, Patient 2 expressed a mixture of IgA, IgM and IgG and both fractions bound to PF4 alone or to H-PF4 complexes. Finally. IgG in patient 3 only bound to H-PF4 and was unreactive with PF4 alone. Using [C-14]-serotonin release assays, the antibodies developed in the three patients and exhibiting the strongest ability to activate platelets with heparin were those having the highest affinity to H-PF4. These results strongly support the hypothesis that HIT antibodies to PF4 are heterogeneous regarding their affinity and specificity for target antigens and this may greatly influence their ability to activate platelets and their pathogenicity.
引用
收藏
页码:336 / 341
页数:6
相关论文
共 50 条
  • [1] Affinity-purification of different heparin-dependent antibodies to platelet factor 4 developed in heparin-induced thrombocytopenia. Biological characteristics and effects on platelet activation.
    Pouplard, CA
    Amiral, J
    Vissac, AM
    Walenga, JM
    Jeske, WP
    Gruel, YJ
    [J]. BLOOD, 1999, 94 (10) : 16A - 16A
  • [2] Measurement of heparin-dependent platelet antibodies in the diagnosis of heparin-induced thrombocytopenia: Fact or fiction?
    Parker, Robert I.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (07) : 1784 - 1785
  • [3] Platelet factor 4, target of heparin-dependent antibodies. Application for the biological diagnostic of heparin induced thrombocytopenia.
    Amiral, J
    [J]. ANNALES DE MEDECINE INTERNE, 1997, 148 (02): : 142 - 149
  • [4] DETECTION OF HEPARIN-DEPENDENT PLATELET AGGREGATING FACTORS IN PATIENTS WITH HEPARIN-INDUCED THROMBOCYTOPENIA
    CHANG, JC
    [J]. CLINICAL RESEARCH, 1987, 35 (03): : A421 - A421
  • [5] Heparin-Dependent Antibodies and Thrombosis without Heparin-Induced Thrombocytopenia
    Bream-Rouwenhorst, Heather R.
    Hobbs, Ryan A.
    [J]. PHARMACOTHERAPY, 2008, 28 (11): : 1401 - 1407
  • [6] Prevalence of heparin-induced thrombocytopenia (HIT) and of heparin-dependent anti-platelet antibodies using platelet factor 4(PF4)/heparin ELISA in hemodialysis patients - A multicenter study
    Kim, YL
    Park, DC
    Kim, SR
    Hwang, JH
    Bang, JH
    Kwon, TH
    Cho, DK
    Suh, JS
    [J]. KIDNEY INTERNATIONAL, 1997, 51 (03) : 952 - 952
  • [7] The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia
    Gerotziafas, GT
    Elalamy, I
    Lecrubier, C
    Lebrazi, J
    Mirshahi, M
    Potevin, F
    Lecompte, T
    Samama, MM
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2001, 12 (07) : 511 - 520
  • [8] A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies
    Jones, Curtis G.
    Pechauer, Shannon M.
    Curtis, Brian R.
    Bougie, Daniel W.
    Irani, Mehraboon S.
    Dhakal, Binod
    Pierce, Brenda
    Aster, Richard H.
    Padmanabhan, Anand
    [J]. CHEST, 2017, 152 (04) : E77 - E80
  • [9] Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
    Pouplard, C
    Iochmann, S
    Renard, B
    Herault, O
    Colombat, P
    Amiral, J
    Gruel, Y
    [J]. BLOOD, 2001, 97 (10) : 3300 - 3302
  • [10] The prevalence of heparin-induced thrombocytopenia (HIT) and of heparin-dependent anti-platelet antibodies using platelet factor 4 (PF4)/heparin ELISA in hemodialysis patients - Multicenter study.
    Kwon, TH
    Baek, MY
    Kim, SJ
    Kim, JH
    Kim, YL
    Cho, DK
    Suh, JS
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1996, 7 (09): : A1200 - A1200